During the past decade, Urologie Neandertal Praxis Mettmann conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Urologie Neandertal Praxis Mettmann" are "Abiraterone Acetate" (1 trials), "Androgens" (1 trials), "Antineoplastic Agents" (1 trials), "Antineoplastic Agents, Hormonal" (1 trials) and "Cyclin-Dependent Kinase 4" (1 trials). Many other conditions were trialed in "Urologie Neandertal Praxis Mettmann" in a lesser frequency.

Most popular intervention types in "Urologie Neandertal Praxis Mettmann" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (2 trials), "Prednisone" (2 trials), "Abiraterone" (1 trials), "Abiraterone Acetate" (1 trials) and "Abiraterone acetate (AA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urologie Neandertal Praxis Mettmann" are 3 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Urologie Neandertal Praxis Mettmann". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Urologie Neandertal Praxis Mettmann, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Urologie Neandertal Praxis Mettmann, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".